Contact Us marketing@medicilon.com
Medicilon Logo
|
search icon search icon 中 contact icon menu icon
Medicilon Logo
|
search icon close search icon 中 contact icon menu icon
ABOUT
Company Profile
Corporate Culture
Management Team
Company History
Message from the CEO
Honors and Awards
Over 20 years of experience in R&D
Learn more
01 Drug Discovery
Chemistry Research
Biology Research
Early Pharmacokinetics
02 Pharmaceutical Research
Intermediates
Active Pharmaceutical Ingredients
Pharmaceutical preparation
Analytical Method Development and Quality Control
CMC Filings
Analytical Testing Center
03 Preclinical Research
Pharmacology & Pharmacodynamics
Drug Safety Evaluation
DMPK
Bioanalysis
IND Filings
01 One-stop Integrated Services
Liposome Drug Development
Drug Discovery
Pharmaceutical Research
Preclinical Research
Botanical Drug Preclinical R&D
02 Innovative Drug Services
ADC
PROTAC
mRNA Vaccine
Cellular Immunotherapies
Nucleic Acid Drug
Peptide Drug Conjugate (PDC)
Antibody
03 Key Technical Services for Drug R&D
Cytokine and Biomarker Detection
Metabolite Identification (MetID)
Drug Forming Research
Flow Cytometry Technology
SEND Format Conversion
Flow Sorting
NanoString nCounter Detection
Routes of Drug Administration
04 Drug Efficacy Evaluation for Common Diseases
IO Pharmacodynamic Model
Inflammatory and Immune Diseases
Rodent Cerebrovascular Disease
05 Advanced Preparation R&D
Inhalation drug
Ophthalmic drug
Skin Topical Preparation
06 Targeted Drugs R&D Services
STAT3-targeted Drugs R&D Service
GLP-1 New Drug R&D Service
KRAS-targeted Drugs R&D Service
CAREERS
Talent Development
Campus Recruitment
Recruitment
Campus Recruitment
Campus Recruitment
Recruitment
Recruitment
News
Medicilon Events
Featured Stories
Market Events
Videos
A.C.E.
2024-07-22Medicilon Events
The Shanghai Overseas Returned Scholars Association invites the Dutch PhD delegation to visit Medicilon, exploring paths for innovative development together
On July 4th, the Shanghai Overseas Returned Scholars Association invited the Dutch PhD delegation to visit the Chuansha campus of Shanghai Medicilon Inc. (Medicilon) and held discussions with Medicilon's Founder and CEO, Chunlin Chen, among others.
Learn more
2024-07-22Medicilon Events
5th consecutive win! Medicilon once again made the list of "Top 20 Chinese R&D CRO Enterprises in 2024"
Medicilon stood out among hundreds of pharmaceutical enterprises and was honored with the "Top 20 Chinese R&D CRO Enterprises in 2024" award.
Learn more
INVESTORS
Stock Information
Investment Contact
Medicilon 688202
RMB

As of Beijing time The data is from a third-party organization and is only for reference.

For actual information, please refer to：www.eastmoney.com

CLIENT CENTER
Intellectual Property Protection
Clients Testimonials
Downloads
Partnerships
Medicilon Support
Newsletters
U.S.

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880

UK

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954

Email: marketing@medicilon.com

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Close

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3

Shanghai Public Network Security File No. 31011502018888 | Website Map

© 2023 Shanghai Medicilon Inc. All rights reserved Shanghai ICP No.10216606-3
Shanghai Public Network Security File No. 31011502018888|Website Map
关闭
中
Message
Contact Us
Close Button
Back To Top
Online Message×
Click switch
Close Button
News and Events
Medicilon Events Featured Stories Market Events Videos A.C.E.
HomenewsFeatured Stories

Featured Stories

Hot information：
Top 10 Global CDMO Enterprises| The Meaning of IND, NDA and ANDA| Top 10 Global Clinical Research Organizations in 2021
Dec 21,2017
International Team Discovers New Multi-Disease Target
Scientists say a protein in a chain that regulates iron and other elements in cells could provide a new target to treat cancer, diabetes and other diseases. A team of researchers at Rice University, the University of California at San Diego (UCSD), the Hebrew University of Jerusalem and the University of North Texas detailed theRead more
More
Dec 21,2017
Novel Nanoparticles Designed to Bind to and Destroy Viruses
Over the last decade, advances in nanotechnology have resulted in scientists creating amazingly specific nanoparticles that can travel through a human body and home in on specific cells. The latest nanoparticle innovation, driven by advanced computer modeling technologies, targets a broad range of devastating viruses and not only binds to them, but destroys them as well.Read more
More
Dec 21,2017
Memorabilia of the global biopharmaceutical CRO/CDMO industry in 2017
Unknowingly, biological drugs have occupied a leading position in the TOP10 list of global best-selling drugs, and Xiu Mei Le has been awarded the title of "Pharmaceutical King” for many years. There is no doubt that the popularity of biological medicine has overshadowed chemical medicine in recent years.
More
Dec 21,2017
The latest prevention/treatment targets for diabetic nephropathy
The Shang-Zhong Xu group of the Cardiovascular and Metabolic Research Center of the University of Hull in the United Kingdom and the Zeng Bo group of the Institute of Cardiovascular Medicine, Southwest Medical University, China published a titled "ORAI channels are critical for” in "Nature Communications”. "Receptor-mediated endocytosis of albumin” article, using human cell models,Read more
More
Dec 20,2017
Opioid Abuse May Be Curbed by New Vaccine
A new vaccine may be effective in combating the growing opioid problem plaguing the nation. Researchers from the U.S. Military HIV Research Program at the Walter Reed Army Institute of Research (WRAIR) have found that an experimental heroin vaccine induced antibodies that prevented the drug from crossing the blood-brain barrier in mice and rats. TheRead more
More
Dec 20,2017
Unique Genetic Profile for Lewy Body Dementia Uncovered
Lewy body dementia (LBD) is a disease associated with abnormal deposits of a protein called α-synuclein in the brain. These deposits, called Lewy bodies, affect neurons in the brain and lead to problems with thinking, movement, behavior, and mood. LBD is one of the most common causes of dementia, after Alzheimer's disease and vascular disease.
More
Unique Genetic Profile for Lewy Body Dementia Uncovered
Dec 19,2017
Advanced Computational Methods May Lead to New Peptide Drugs
New computational strategies reported that might help realize the promise of peptide-based drugs. Peptides are similar to protein molecules, but differ in their smaller size, structure and functions. In addition, peptides such as cyclosporine are stable like small molecules and selective like antibodies. The scientists explain that naturally occurring peptides that might serve as scaffoldsRead more
More
Advanced Computational Methods May Lead to New Peptide Drugs
Dec 19,2017
New Diagnostic Biomarkers and Method Uncovered for MS
Compounding the already difficult diagnosis of multiple sclerosis (MS) is the onslaught of invasive, often painful, tests to identify and track disease progression – typically requiring the collection of fluid from the brain and spine. However, now, investigators at the University of Huddersfield, U.K., have just developed a minimally invasive method for quickly detecting signsRead more
More
New Diagnostic Biomarkers and Method Uncovered for MS
Dec 18,2017
Virus-Like Synthetic Nucleocapsid Carries Own RNA Genome, Evolves
It's a protective shell, very much like those used by viruses to package and ferry their genomes. This shell, however, is built from computer-designed proteins – which sounds fairly innocuous. Such a shell, should it be used to encapsulate a drug, might facilitate the drug's delivery. It's not anything that could advance research into artificialRead more
More
Virus-Like Synthetic Nucleocapsid Carries Own RNA Genome, Evolves
Dec 18,2017
Novel Finding on Memory T Cells May Provide Boost to Cancer Immunotherapy
Like employees cross-trained for different jobs, scientists have the strongest evidence yet that memory T cells responsible for long-term immune protection arises from effector CD8 T cells.   The finding provides insight that should help researchers design more effective vaccines and expand cancer immunotherapies by aiding efforts to harness the immune cells to prevent or cureRead more
More
Stock Code
688202

Global

Address: 20 Maguire Road, Suite 103, Lexington, MA 02421(America)

Tel: +1(626)986-9880(U.S.)

Address: Allia Future Business Centre Kings Hedges Road Cambridge CB4 2HY, UK

Tel: 0044 7790 816 954 (Europe)

Email: marketing@medicilon.com

  

Address: 5th Floor, 62, Banpodae-ro 4-gil, Seocho-gu, Seoul, 06719 South Korea

Tel: +82 70-8269-5849

China

Address: No.585 Chuanda Road, Pudong New Area, Shanghai (Headquarters)

Postcode: 201299

Tel: +86 (21) 5859-1500 (main line)

Fax: +86 (21) 5859-6369

Facebook icon
Twitter icon
Linkedin icon
Youtube icon
© 2023 Shanghai Medicilon Inc. All rights reserved All Rights Reserved Privacy Policy
Website Map
-->